{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:02:40Z","timestamp":1791820960508,"version":"4.3.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,5,17]],"date-time":"2018-05-17T00:00:00Z","timestamp":1526515200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s00011-018-1157-4","type":"journal-article","created":{"date-parts":[[2018,5,17]],"date-time":"2018-05-17T07:48:44Z","timestamp":1526543324000},"page":"671-679","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["IL-33\/s-ST2 ratio, systemic symptoms, and basophil activation in Pru p 3-sensitized allergic patients"],"prefix":"10.1007","volume":"67","author":[{"given":"Carina G.","family":"Uasuf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina Di","family":"Sano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiano","family":"Gangemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Albeggiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Cigna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Dino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignazio","family":"Brusca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Gjomarkaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1141-9010","authenticated-orcid":false,"given":"Elisabetta","family":"Pace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,17]]},"reference":[{"key":"1157_CR1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nri2691","volume":"10","author":"JE Sims","year":"2010","unstructured":"Sims JE, Smith DE. The IL-1 family: regulators of immunity. Nat Rev Immunol. 2010;10:89\u2013102.","journal-title":"Nat Rev Immunol"},{"key":"1157_CR2","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/j.1365-2222.2011.03867.x","volume":"42","author":"RTKMNT KamekuraKojimaTakanoGoSawadaHimi","year":"2012","unstructured":"Kamekura R, Kojima T, Takano K, Go M, Sawada N, Himi T. The role ofIL-33 and its receptor ST2 in human nasal epithelium with allergic rhinitis. Clin Exp Allergy. 2012;42:218\u201328.","journal-title":"Clin Exp Allergy"},{"key":"1157_CR3","doi-asserted-by":"crossref","unstructured":"Lee JH, Wang LC, Yu HH, Lin YT, Yang YH, Chiang BL. Type I IL-1 receptor (IL-1RI) as potential new therapeutic target for bronchial asthma. Mediat Inflamm. 2010 (Epub 5 2010).","DOI":"10.1155\/2010\/567351"},{"issue":"6","key":"1157_CR4","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s00011-012-0443-9","volume":"61","author":"J Gl\u00fcck","year":"2012","unstructured":"Gl\u00fcck J, Rymarczyk B, Rogala B. Serum IL-33 but not ST2 level is elevated in intermittent allergic rhinitis and is a marker of the disease severity. Inflamm Res. 2012;61(6):547\u201350.","journal-title":"Inflamm Res"},{"key":"1157_CR5","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1111\/all.12004","volume":"67","author":"T Ohno","year":"2012","unstructured":"Ohno T, Morita H, Arae K, Matsumoto K, Nakae S. Interleukin-33 in allergy. Allergy. 2012;67:1203\u201314.","journal-title":"Allergy"},{"key":"1157_CR6","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.jaad.2014.01.867","volume":"70","author":"R Tamagawa-Mineoka","year":"2014","unstructured":"Tamagawa-Mineoka R, Okuzawa Y, Masuda K, Katoh N. Increased serum levels of interleukin 33 in patients with atopic dermatitis. J Am Acad Dermatol. 2014;70:882\u20138.","journal-title":"J Am Acad Dermatol"},{"key":"1157_CR7","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.jaci.2009.12.935","volume":"125","author":"D Pr\u00e9fontaine","year":"2010","unstructured":"Pr\u00e9fontaine D, Nadigel J, Chouiali F, Audusseau S, Semlali A, Chakir J, Martin JG, Hamid Q. Increased IL-33 expression by epithelial cells in bronchial asthma. J Allergy Clin Immunol. 2010;125:752\u20134.","journal-title":"J Allergy Clin Immunol"},{"key":"1157_CR8","doi-asserted-by":"publisher","first-page":"5094","DOI":"10.4049\/jimmunol.0802387","volume":"183","author":"D Pr\u00e9fontaine","year":"2009","unstructured":"Pr\u00e9fontaine D, Lajoie-Kadoch S, Foley S, Audusseau S, Olivenstein R, Halayko AJ, Lemi\u00e8re C, Martin JG, Hamid Q. Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells. J Immunol. 2009;183:5094\u2013103.","journal-title":"J Immunol"},{"issue":"1","key":"1157_CR9","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jaci.2012.08.002","volume":"131","author":"DK Chu","year":"2013","unstructured":"Chu DK, Llop-Guevara A, Walker TD, Flader K, Goncharova S, Boudreau JE, Moore CL, Seunghyun In T, Waserman S, Coyle AJ, Kolbeck R, Humbles AA, Jordana M. IL-33, but not thymic stromal lymphopoietin or IL-25, is central to mite and peanut allergic sensitization. J Allergy Clin Immunol. 2013;131(1):187\u2013200.","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"1157_CR10","doi-asserted-by":"publisher","first-page":"4965","DOI":"10.1172\/JCI75660","volume":"124","author":"L Tordesillas","year":"2014","unstructured":"Tordesillas L, Goswami R, Bened\u00e9 S, Grishina G, Dunkin D, J\u00e4rvinen KM, Maleki SJ, Sampson HA, Berin MC. Skin exposure promotes a Th2-dependent sensitization to peanut allergens. J Clin Invest 2014;124(11):4965\u201375.","journal-title":"J Clin Invest"},{"key":"1157_CR11","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1159\/000222679","volume":"150","author":"R Asero","year":"2009","unstructured":"Asero R, Antonicelli L, Arena A, Bommarito L, Caruso B, et al. Causes of food-induced anaphylaxis in Italian adults: a multi-centre study. Int Arch Allergy Immunol. 2009;150:271\u20137.","journal-title":"Int Arch Allergy Immunol"},{"key":"1157_CR12","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.jaci.2006.05.012","volume":"118","author":"M Fernandez-Rivas","year":"2006","unstructured":"Fernandez-Rivas M, Bolhaar S, Gonzalez-Mancebo E, Asero R, van Leeuwen A, et al. Apple allergy across Europe: how allergen sensitization profiles determine the clinical expression of allergies to plant foods. J Allergy Clin Immunol. 2006;118:481\u20138.","journal-title":"J Allergy Clin Immunol"},{"key":"1157_CR13","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/ACI.0b013e32814a5401","volume":"7","author":"L Zuidmeer","year":"2007","unstructured":"Zuidmeer L, van Ree R. Lipid transfer protein allergy: primary food allergy or pollen\/food syndrome in some cases. Curr Opin Allergy Clin Immunol. 2007;7:269\u201327.","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"1157_CR14","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1007\/s11882-010-0128-9","volume":"10","author":"M Egger","year":"2010","unstructured":"Egger M, Hauser M, Mari A, Ferreira F, Gadermaier G. The role of lipid transfer proteins in allergic diseases. Curr Allergy Asthma Rep. 2010;10:326\u201335.","journal-title":"Curr Allergy Asthma Rep"},{"key":"1157_CR15","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1111\/j.1398-9995.2004.00466.x","volume":"59","author":"C Bindslev-Jensen","year":"2004","unstructured":"Bindslev-Jensen C, Ballmer-Weber BK, Bengtsson U, Blanco C, Ebner C, Hourihane J, Knulst AC, Moneret-Vautrin DA, Nekam K, Niggemann B, Osterballe M, Ortolani C, Ring J, Schnopp C, Werfel T. Standardization of food challenges in patients with immediate reactions to foods\u2014position paper from the European Academy of Allergology and Clinical Immunology. Allergy. 2004;59:690\u20137.","journal-title":"Allergy"},{"key":"1157_CR16","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/j.jaci.2014.06.029","volume":"134","author":"YC Chan","year":"2014","unstructured":"Chan YC, Ramadani F, Santos AF, Pillai P, Ohm-Laursen L, Harper CE, Fang C, Dodev TS, Wu SY, Ying S, Corrigan CJ, Gould HJ. \u201cAuto-anti-IgE\u201d: naturally occurring IgG anti-IgE antibodies may inhibit allergen-induced basophil activation. J Allergy Clin Immunol. 2014;134:1394\u2013401.","journal-title":"J Allergy Clin Immunol"},{"key":"1157_CR17","doi-asserted-by":"crossref","unstructured":"Liew FY, Pitman NI, McInnes IB. Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat Rev 2010; 103\u201310.","DOI":"10.1038\/nri2692"},{"key":"1157_CR18","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1016\/j.bbadis.2014.06.009","volume":"1842","author":"E Pace","year":"2014","unstructured":"Pace E, Di Sano C, Sciarrino S, Scafidi V, Ferraro M, Chiappara G, Siena L, Gangemi S, Vitulo P, Giarratano A. Gjomarkaj M Cigarette smoke alters IL-33 expression and release in airway epithelial cells. Biochim Biophys Acta. 2014;1842:1630\u20137.","journal-title":"Biochim Biophys Acta"},{"key":"1157_CR19","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1254\/jphs.14R12CP","volume":"126","author":"T Nabe","year":"2014","unstructured":"Nabe T. Interleukin (IL)-33: new therapeutic target for atopic diseases. J Pharmacol Sci. 2014;126:85\u201391.","journal-title":"J Pharmacol Sci"},{"issue":"4","key":"1157_CR20","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1159\/000324440","volume":"156","author":"EA Pastorello","year":"2011","unstructured":"Pastorello EA, Farioli L, Pravettoni V, Scibilia J, Mascheri A, Borgonovo L, Piantanida M, Primavesi L, Stafylaraki C, Pasqualetti S, Schroeder J, Nichelatti M, Marocchi A. Pru p\u00a03-sensitised Italian peach-allergic patients are less likely to develop severe symptoms when also presenting IgE antibodies to Pru p\u00a01 and Pru p\u00a04. Int Arch Allergy Immunol. 2011;156(4):362\u201372.","journal-title":"Int Arch Allergy Immunol"},{"key":"1157_CR21","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12948-015-0035-7","volume":"13","author":"CG Uasuf","year":"2015","unstructured":"Uasuf CG, Villalta D, Conte ME, Di Sano C, Barrale M, Cantisano V, Pace E, Gjomarkaj M, Gangemi S, Brusca I. Different co-sensitizations could determine different risk assessment in peach allergy? Evaluation of an anaphylactic biomarker in Pru p\u00a03 positive patients. Clin Mol Allergy. 2015;13:30.","journal-title":"Clin Mol Allergy"},{"issue":"12","key":"1157_CR22","doi-asserted-by":"publisher","first-page":"e48816","DOI":"10.1371\/journal.pone.0048816","volume":"7","author":"E Pace","year":"2012","unstructured":"Pace E, Di Sano C, La Grutta S, Ferraro M, Albeggiani G, Liotta G, Di Vincenzo S, Uasuf CG, Bousquet J, Gjomarkaj M. Multiple in vitro and in vivo regulatory effects of budesonide in CD4 + T lymphocyte subpopulations of allergic asthmatics. PLoS One. 2012;7(12):e48816.","journal-title":"PLoS One"},{"issue":"2","key":"1157_CR23","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1164\/rccm.2008161","volume":"166","author":"H Shen","year":"2002","unstructured":"Shen H, O\u2019Byrne PM, Ellis R, Wattie J, Tang C, Inman MD. The effects of intranasal budesonide on allergen-induced production of interleukin-5 and eotaxin, airways, blood, and bone marrow eosinophilia, and eosinophil progenitor expansion in sensitized mice. Am J Respir Crit Care Med. 2002;166(2):146\u201353.","journal-title":"Am J Respir Crit Care Med"},{"key":"1157_CR24","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ejphar.2015.03.015","volume":"757","author":"T Nabe","year":"2015","unstructured":"Nabe T, Wakamori H, Yano C, Nishiguchi A, Yuasa R, Kido H, Tomiyama Y, Tomoda A, Kida H, Takiguchi A, Matsuda M, Ishihara K, Akiba S, Ohya S, Fukui H, Mizutani N, Yoshino S. Production of interleukin (IL)-33 in the lungs during multiple antigen challenge-induced airway inflammation in mice, and its modulation by a glucocorticoid. Eur J Pharmacol. 2015;757:34\u201341.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"1157_CR25","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.jaci.2016.09.049","volume":"140","author":"R Joulia","year":"2017","unstructured":"Joulia R, L\u2019Faqihi FE, Valitutti S, Espinosa E. IL-33 fine tunes mast cell degranulation and chemokine production at the single-cell level. J Allergy Clin Immunol. 2017;140(2):497\u2013509.","journal-title":"J Allergy Clin Immunol"},{"key":"1157_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201545501","author":"G Bandara","year":"2015","unstructured":"Bandara G, Beaven MA, Olivera A, Gilfillan AM, Metcalfe DD. Activated mast cells synthesize and release soluble ST2-a decoy receptor for IL-33. Eur J Immunol. 2015. https:\/\/doi.org\/10.1002\/eji.201545501 .","journal-title":"Eur J Immunol"},{"key":"1157_CR27","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3389\/fimmu.2017.00475","volume":"8","author":"B Griesenauer","year":"2017","unstructured":"Griesenauer B, Paczesny S. The ST2\/IL-33 axis in immune cells during inflammatory diseases. Front Immunol. 2017;8:475.","journal-title":"Front Immunol"},{"key":"1157_CR28","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S1081-1206(10)62167-9","volume":"91","author":"WW Storms","year":"2003","unstructured":"Storms WW. Minimal persistent inflammation, an emerging concept in the nature and treatment of allergic rhinitis: the possible role of leukotrienes. Ann Allergy Asthma Immunol. 2003;91:131\u201340.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"1157_CR29","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/S1081-1206(10)62849-9","volume":"83","author":"GW Canonica","year":"1999","unstructured":"Canonica GW, Ciprandi G. Minimal persistent inflammation may be controlled by cetirizine. Ann Allergy Asthma Immunol. 1999;83:445\u20138.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"1157_CR30","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.jaci.2014.09.044","volume":"135","author":"PE Pfeffer","year":"2015","unstructured":"Pfeffer PE, Chen YH, Woszczek G, Matthews NC, Chevretton E, Gupta A, Saglani S, Bush A, Corrigan C, Cousins DJ, Hawrylowicz CM. Vitamin D enhances production of soluble ST2, inhibiting the action of IL-33. J Allergy Clin Immunol. 2015;135(3):824\u20137.","journal-title":"J Allergy Clin Immunol"},{"key":"1157_CR31","doi-asserted-by":"crossref","unstructured":"Koplin JJ, Suaini NH, Vuillermin P, Ellis JA, Panjari M, Ponsonby AL, Peters RL, Matheson MC, Martino D, Dang T, Osborne NJ, Martin P, Lowe A, Gurrin LC, Tang ML, Wake M, Dwyer T, Hopper J, Dharmage SC, Allen KJ. HealthNuts Study. Polymorphisms affecting vitamin D-binding protein modify the relationship between serum vitamin D (25[OH]D3) and food allergy. J Allergy Clin Immunol. 2015. (pii: S0091-6749(15)00911-2).","DOI":"10.1016\/j.jaci.2015.05.051"},{"issue":"1","key":"1157_CR32","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.bbrc.2014.06.111","volume":"451","author":"D Shao","year":"2014","unstructured":"Shao D, Perros F, Caramori G, Meng C, Dormuller P, Chou PC, Church C, Papi A, Casolari P, Welsh D, Peacock A, Humbert M, Adcock IM, Wort SJ. Nuclear IL-33 regulates soluble ST2 receptor and IL-6 expression in primary human arterial endothelial cells and is decreased in idiopathic pulmonary arterial hypertension. Biochem Biophys Res Commun. 2014;451(1):8\u201314.","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00011-018-1157-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-018-1157-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-018-1157-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T20:48:30Z","timestamp":1661287710000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00011-018-1157-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,17]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["1157"],"URL":"https:\/\/doi.org\/10.1007\/s00011-018-1157-4","relation":{},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"value":"1023-3830","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,17]]},"assertion":[{"value":"21 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No conflicts of interest or disclosures to be made by any of the authors.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}}]}}